Aim. Cardiovascular (CV) disease is the leading cause of death in unselected patients with non-alcoholic fatty liver disease (NAFLD). Although the need of a multidisciplinary approach is highlighted in guidelines, there is lack of data to demonstrate its effectiveness. We assessed the efficacy of a multidisciplinary clinic through control of metabolic comorbidities and surrogate markers of liver involvement. Methods. Prospectively collected data of 273 patients referred to a multidisciplinary NAFLD clinic, comprehensive of a hepatological consultation, cardiovascular risk assessment and dietetic counseling were analyzed. Results. Mean age was 56.4±12.1 years, with 57% males. The median follow-up was 18 months. The prevalence of obesity, hypertension and diabetes was 60%, 67% and 50% respectively, while 13.2% had a positive history of CV events. At baseline, dyslipidaemia management was suboptimal in 64 patients (25.2%), while 57 (41.9%) patients with diabetes and 36 (19.6%) patients with hypertension needed modification of their treatment. During follow-up, there were statistically significant improvements in ALT (p=0.013), AST (p=0.013), systolic and diastolic blood pressure (p=0.002 and 0.014 respectively), total cholesterol (p<0.001) and glycated haemoglobin in diabetic patients (70.2 to 62.5 mmol/mol, p=0.04). 142 patients (52%) achieved weight loss during the follow-up (≥10%, ≥7% and ≥5% in 8.2%, 6% and 7.3% of the cohort respectively). The total number of patients with a QRISK3 score≥10% decreased from 156 (62.7%) to 97 (48.5%). Conclusions. A multidisciplinary NAFLD approach was effective in improving liver-related and CV risk factors. A strong collaboration between primary and secondary care is essential to implement and maintain these improvements in the long term.